样式: 排序: IF: - GO 导出 标记为已读
-
Barriers to accessing post-pregnancy contraception in Brazil: The impact of COVID-19 Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-23 Cássia R.T. Juliato, Montas Laporte, Fernanda Surita, Luis Bahamondes
The aim of our article is to discuss barriers associated with post-pregnancy contraception in Brazil during the SARS-CoV-2 (COVID-19) pandemic. Socioeconomic differences in gaining access to long-acting reversible contraceptive (LARC) methods became greater during the COVID-19 pandemic. The inadequate distribution of existing resources and the reduced capacity for elective care meant that healthcare
-
Preeclampsia epidemiology(ies) and pathophysiology(ies) Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-22 James M. Roberts
Preeclampsia/eclampsia was first described 2000 years ago. Concepts guiding diagnosis have changed over time making longitudinal studies challenging. Similarly, concepts of pathophysiology have evolved from eclampsia as a pregnancy seizure disorder to preeclampsia as a hypertensive and renal disorder to our current concept of a preeclampsia as a pregnancy specific, multisystemic inflammatory disorder
-
Psychiatric emergencies during pregnancy and puerperium in low - And middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-21 Lindokuhle Thela, Saeeda Paruk, Busisiwe Bhengu, Bonginkosi Chiliza
Pregnancy and puerperium are critical points in women’s health, and various psychiatric emergencies may worsen or manifest (for the first time) during this period. In the presence of a psychiatric emergency, the pregnancy and puerperium outcomes may be compromised. In addition to the mother being at risk, the health of the fetus and the newborn may also be compromised if the psychiatric emergency is
-
Peripartum cardiomyopathy in low- and middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-17 Emmanuel C. Ejim, Kamilu M. Karaye, Samuel Antia, Godsent C. Isiguzo, Paschal O. Njoku
Peripartum cardiomyopathy (PPCM) causes pregnancy-associated heart failure, typically during the last month of pregnancy, and up to 6 months post-partum, in women without known cardiovascular disease.
-
Management of placenta accreta spectrum in low- and middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-17 Albaro José Nieto-Calvache, Jose M. Palacios-Jaraquemada, Ahmed M. Hussein, Eric Jauniaux, Conrado Milani Coutinho, Marcus Rijken
Placenta accreta spectrum (PAS) can be associated massive intra- and post-operative hemorrhage which when not controlled can lead to maternal death. Important advances have occurred in understanding the pathophysiology and therapeutic options for this condition. The prevalence of PAS at birth is direct association with the cesarean delivery (CD) rate in the corresponding population and is increasing
-
Venous thromboembolism in pregnant obese Individuals Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-16 Osric B. Navti, Sue Pavord
Venous thrombosis and thromboembolism (VTE) remain the leading cause of direct maternal deaths, occurring within 42 days of the end of pregnancy in the UK. Pregnancy is associated with an overall 10-fold higher incidence of VTE than in the non-pregnant state and has been reported to reach up to 30-fold higher in the puerperium. This increased risk is further exacerbated by maternal obesity in a relationship
-
Sentinel Lymph node detection in endometrial cancer - Anatomical and scientific facts Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 Rainer Kimmig, Fabinshi Thangarajah, Paul Buderath
Anatomical and functional aspects of the lymphatic drainage of the uterine corpus in endometrial cancer are demonstrated. Main lymphatic pathway runs along the upper pelvic pathway from the uterine artery first line to the medial external iliac nodes, followed by the lateral external and common iliac node basin. The second important pathway runs along the ovarian vessels directly to the paraaortic
-
Preventing maternal morbidity and mortality from preeclampsia and eclampsia particularly in low- and middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 Nnabuike Chibuoke Ngene, Jagidesa Moodley
Preeclampsia (PE) is a complex heterogeneous disorder with overlapping clinical phenotypes that complicate diagnosis and management. Although several pathophysiological mechanisms have been proposed, placental dysfunction due to inadequate remodelling of uterine spiral arteries leading to mal-perfusion and syncytiotrophoblast stress is recognized as the unifying characteristic of early-onset PE. Placental
-
Maternal high-care and intensive care units in low- and middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 José Rojas-Suarez, Fathima Paruk
Despite notable advancements in minimizing maternal mortality during recent decades, a pronounced disparity persists between high-income nations and low-to middle-income countries (LMICs), particularly in intensive and high-care for pregnant and postpartum individuals. This divergence is multifactorial and influenced by factors such as the availability and accessibility of community-based maternity
-
Robotic-assisted fertility sparing surgery in gynecological oncology Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 Christos Iavazzo, Kalliopi Kokkali, Emmanouil Kaouras, Alexandros Fotiou
While gynecological malignancies are more commonly diagnosed in elderly women, a substantial proportion of women will still be diagnosed with some type of gynecologic cancer during their reproductive age. Over 10% of newly diagnosed ovarian cancers and over one third of newly diagnosed cervical cancers involve women who are under the age of 45. This, coupled with the rising trend of women having their
-
Prevention of preeclampsia Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 Fiona Brownfoot, Daniel Lorber Rolnik
Preeclampsia is a relatively common pregnancy complication and constitutes a major cause of morbidity and mortality for mothers and children worldwide. It disproportionally affects low-resource countries. Appropriate identification of individuals at increased risk and prevention of the disease and its complications remain healthcare and research priorities, and the investigation of potential interventions
-
Perineal injuries during vaginal birth in low-resource countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-15 S. Ramphal, A.H. Sultan
Birth related perineal trauma (BRPT) and obstetric anal sphincter injuries (OASIS) are leading causes of anal incontinence in women, which negatively impacts on their quality of life, resulting in low self-esteem and abandonment. In low resource countries (LRC), the true incidence is not known and since most births are unattended or occur in community-based health care systems, one can anticipate that
-
Post-pregnancy family planning in Southeast Asia with a focus on novel training techniques Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-14 Kusum Thapa, Sapana Amatya, Anil Thapa, Meghan Greeley
Postpartum Family Planning is a critical strategy in the first 12 months post-childbirth. It aims to prevent unintended, closely spaced pregnancies and thereby help reducing maternal, neonatal as well as child morbidity and mortality. Despite its significance, many women remain without contraception despite a desire to avoid pregnancy. The World Health Organization suggests a 24-month inter-pregnancy
-
An overview of diabetes mellitus in pregnant women with obesity Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-10 Mohammed Bashir, Yassin Fagier, Badreldeen Ahmed, Justin C Konje
Rates of obesity are increasing world-wide with an estimated 1billion people projected to be obese by 2030 if current trends remain unchanged. Obesity currently considered one of the most significant associated factors of non-communicable diseases poses the greatest threat to health. Diabetes mellitus is an important metabolic disorder closely associated with obesity. It is therefore expected that
-
Preface Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-02-06 Justin C. Konje, Badreldeen Ahmed
-
-
Chapter 11. Endometriosis-related complications in women undergoing in-vitro fertilization Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-01-12 Laura Melado, Baris Ata
As a chronic inflammatory disease, endometriosis generates fibrosis and anatomic distortion, which add extra-challenges to assisted reproductive technology cycles and requires a personalized approach. Patients with endometriomas have significantly decreased ovarian reserve and the ultrasound examination tends to be challenging, possibly underestimating follicle counts. It is crucial to assess the feasibility
-
Epidemiology of infertility in women with endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-01-03 Umberto Leone Roberti Maggiore, Valentina Chiappa, Marcello Ceccaroni, Giovanni Roviglione, Luca Savelli, Simone Ferrero, Francesco Raspagliesi, Ludovica Spanò Bascio
Endometriosis is a benign, chronic, inflammatory condition affecting up to 10 % of women and characterised by the presence of glands and stroma tissue outside the uterus. Epidemiological and clinical studies demonstrate a consistent association between endometriosis and infertility. However, this relationship is far to be clearly understood and several mechanisms are involved. Available data show that
-
Surgical treatment of deep endometriosis: Impact on spontaneous conception Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2024-01-03 Georgios Grigoriadis, Angelos Daniilidis, Benjamin Merlot, Konstantinos Stratakis, Thomas Dennis, Adrien Crestani, Isabella Chanavaz-Lacheray, Horace Roman
Deep endometriosis (DE) is the most severe form of endometriosis and is commonly associated with infertility. Surgical treatment of DE appears to increase chances of spontaneous conception in appropriately selected patients wishing to conceive. Identifying, however, the exact impact of DE, and its surgical removal, on natural conception is highly challenging. The surgical approach should be favoured
-
Tips and tricks in gynaecological robotic surgery Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-31 Kamana Subba, Esther Lambert, Alaa El-Ghobashy
It was the dawn of a new era for robotic surgery when the Food and Drug Administration (FDA) approved robotic surgical system for general laparoscopic procedures in 2000. The surgical practice saw a transformative breakthrough towards minimally invasive approach with the ever-increasing uptake of advanced robots proven to benefit patients and surgeons in various ways. However, these innovative machines
-
Robot-assisted laparoscopic myomectomy: Technique & brief literature review Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-24 Arnold P. Advincula
The worldwide growth of robot-assisted laparoscopic surgery has been exponential since its FDA approval for use in gynecologic surgery in the spring of 2005. This growth has spanned the entire gamut of gynecologic procedures and pathology. One area that has leveraged the unique aspects of robotics has been its application to the conservative surgical management of uterine fibroids. This manuscript
-
Ethical challenges in obstetric emergencies in low- and middle-income countries Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-17 Patrick Ifeanyi Okonta, Odidika Ugochukwu Joannes Umeora
Obstetric emergencies are challenging, requiring implementation of a rapid sequence of interventions in a very short time to optimize clinical outcome. Managing obstetric emergencies could evoke ethical dilemmas for the obstetrician because of limited time to adequately educate the patient about her condition; impaired consciousness of the patient to give consent; nonexistent prior patient -doctor
-
Contraception after abortion, miscarriage, ectopic and molar pregnancy Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-12 Michelle Cooper, Sharon Cameron
Regardless of whether a pregnancy ends in abortion, miscarriage or ectopic pregnancy, fertility and sexual activity can resume quickly. For those who do not plan to become pregnant again immediately, effective contraception is therefore required. Although a contraceptive discussion and the offer to provide contraception is considered an integral part of abortion care, health care providers may not
-
Role of ultrasonography in the diagnosis of endometriosis in infertile women: Ovarian endometrioma, deep endometriosis, and superficial endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-10 Samantha Tan, Mathew Leonardi, Glen Lo, Emmeline Lee
Endometriosis is a complex chronic inflammatory process characterised by the presence of endometrial-like glandular tissue outside the uterine cavity, typically within the pelvic structures. This condition affects up to 10–15 % of women and those assigned female at birth, and can result in chronic pelvic pain and in/subfertility. Treatment goals include medical, surgical options and alternative therapies
-
Robotic radical hysterectomy after conization for patients with small volume early-stage cervical cancer Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-10 Pluvio J. Coronado, Myriam Gracia
Laparoscopy and robotics are recommended for managing gynecological cancer, as they are associated with lower morbidity and comparable outcomes to open surgery. However, in the case of early cervical cancer, new evidence suggests worse oncological outcomes with these approaches compared to open surgery, though the limited number of robotic cases makes it challenging to draw definitive conclusions for
-
Endometriosis and adenomyosis: Similarities and differences Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-05 Jacques Donnez, Christina Anna Stratopoulou, Dolmans Marie-Madeleine
Deep endometriosis and uterine adenomyosis are two frequently encountered conditions affecting approximately 200 million women worldwide. They are closely related, showing similar histological patterns and multiple common pathogenic features, and share the same symptoms. It is therefore not surprising that they are often thought to have a common developmental origin. Indeed, both deep endometriosis
-
Treatment of endometriomas: Surgical approaches and the impact on ovarian reserve, recurrence, and spontaneous pregnancy Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-12-05 Dana Baraki, Elliott G. Richards, Tommaso Falcone
Endometriomas may contribute to infertility and are associated with diminished ovarian reserve. Surgical management can damage the ovarian cortex and further diminish ovarian reserve. Surgical therapy of endometriomas can be achieved via cystectomy, ablation (electrosurgical, laser, or plasma energy), sclerotherapy, or oophorectomy. Each approach has varying effects on ovarian reserve, spontaneous
-
Endometrial receptivity in women with endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-29 Annalisa Racca, Andrea Bernabeu, Rafael Bernabeu, Simone Ferrero
As endometriosis is recognized as a contributing factor to infertility, prompting couples to embark on Assisted Reproductive Technology (ART) treatments, it becomes crucial to comprehend the extent and way this condition can affect success rates. Natural conception data reveal lower success rates for women with endometriosis, yet the same cannot be extrapolated to the outcomes of in vitro fertilization
-
Spiral, uterine artery doppler and placental ultrasound in relation to preeclampsia Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-28 Tania de Ganzo Suárez, Catalina de Paco Matallana, Walter Plasencia
Preeclampsia (PE) is a multiorgan disorder that complicates around 2–8% of pregnancies and is a major cause of perinatal and maternal morbidity and mortality. PE is a clinical syndrome characterized by hypertension secondary to systemic inflammation, endothelial dysfunction, and syncytiotrophoblast stress leading to hypertension and multiorgan dysfunction. The uterine arteries are the main blood vessels
-
Pregnancy-associated cardiovascular risks and postpartum care; an opportunity for interventions aiming at health preservation and disease prevention Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-27 Nicole Wallin, Lina Bergman, Graeme N. Smith
Cardiovascular disease (CVD) is the leading cause of premature death and disability for female individuals around the world and the rates are increasing in those aged 35–44 years. Certain pregnancy complications (Pregnancy-associated Cardiovascular Risks (P-CVR))are linked to an increased risk of future CVD making pregnancy and the postpartum period as an ideal time to screen individuals for underlying
-
Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-25 Yishan Chen, Shunhe Lin, Xi Xie, Jingsong Yi, Xishi Liu, Sun-Wei Guo
High-intensity focused ultrasound (HIFU) has emerged as a promising uterus-sparing and possibly fertility-sparing treatment modality for women with adenomyosis, especially those who desire to conceive. We conducted this systematic review and performed a meta-analysis on clinical studies aimed to improve reproduction in women with adenomyosis. After extensive search of PubMed and CNKI, we identified
-
Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-25 Piya Chaemsaithong, Mohitosh Biswas, Waranyu Lertrut, Puntabut Warintaksa, Tuangsit Wataganara, Liona CY. Poon, Chonlaphat Sukasem
Preeclampsia is a pregnancy-specific disorder, and it is a leading cause of maternal and perinatal morbidity and mortality. The application of pharmacogenetics to antihypertensive agents and dose selection in women with preeclampsia is still in its infancy. No current prescribing guidelines from the clinical pharmacogenetics implementation consortium (CPIC) exist for preeclampsia. Although more studies
-
10. Role of high dimensional technology in preeclampsia (omics in preeclampsia) Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-18 Lina Youssef, Lea Testa, Francesca Crovetto, Fatima Crispi
Preeclampsia is a pregnancy-specific disease that has no known precise cause. Integrative biology approach based on multi-omics has been applied to identify upstream pathways and better understand the pathophysiology of preeclampsia. At DNA level, genomics and epigenomics studies have revealed numerous genetic variants associated with preeclampsia, including those involved in regulating blood pressure
-
Prediction of preeclampsia in asymptomatic women Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-23 Nikki M.W. Lee, Piya Chaemsaithong, Liona C. Poon
Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. It is important to identify women who are at high risk of developing this disorder in their first trimester of pregnancy to allow timely therapeutic intervention. The use of low-dose aspirin initiated before 16 weeks of gestation can significantly reduce the rate of preterm preeclampsia by 62 %. Effective screening recommended
-
IVF stimulation protocols and outcomes in women with endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-22 Eduardo Goyri, Graciela Kohls, Juan Garcia-Velasco
Endometriosis is a complex medical condition with a high prevalence in women of reproductive age. Fertility is compromised in patients with endometriosis, and success in IVF treatments has been a challenge leading to evaluation of different stimulation protocols. The long-standing debate between GnRH agonist long protocols and short GnRH antagonist protocols is being resolved in favor of the latter
-
Challenges in timing and mode of delivery in morbidly obese women Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-22 Nivedita R. Aedla, Tahir Mahmood, Badreldeen Ahmed, Justin C. Konje
Globally obesity is increasing especially in the reproductive age group. Pregnant women with obesity have higher complication and intervention rates. They are also at increased risk of stillbirth and intrapartum complications. Although organisations like NICE, RCOG, ACOG and WHO have published guidelines and recommendations on care of pregnant women with obesity the evidence from which Grade A recommendations
-
Impact of endometriosis on the ovarian follicles Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-22 Maíra Casalechi, Giorgia Di Stefano, Gianfranco Fornelli, Edgardo Somigliana, Paola Viganò
A significant body of evidence has supported a negative impact of endometriosis on ovarian follicles; however, the origin and relevance of this ovarian impairment in endometriosis is still a matter of debate. The ovarian damage can be caused by endometriosis itself or by surgeries aiming to remove endometriotic lesions. In this review, we summarized the existing knowledge on the mechanisms by which
-
Best practice and research clinical obstetrics and gynaecology volume 92 Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-19 Justin C. Konje, Badreldeen Ahmed
Abstract not available
-
Robotic assisted laparoscopy for deep infiltrating endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-11 T. Hebert
Deep infiltrative endometriosis is a condition affecting up to 15 % of women of childbearing age, defined by extra uterine location of endometrial like tissues. The symptoms of endometriosis range from severe dysmenorrhea to infertility, chronic pelvic pain, bowel dysfunction and urinary tract involvement to name the most common. Endometriosis has an impact on the quality of life of patients, with
-
Robotic-assisted surgery in high-risk surgical patients with endometrial cancer Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-11-04 Anna Collins, Annie Jacob, Esther Moss
Many patients diagnosed with an endometrial cancer are at high-risk for surgery due to factors such as advanced age, raised body mass index or frailty. Minimally-invasive surgery, in particular robotic-assisted, is increasingly used in the surgical management of endometrial cancer however, there are a lack of clinical trials investigating outcomes in high-risk patient populations. This article will
-
Preface: Health economics and outcomes research in reproductive medicine: Methods and comparative effectiveness of treatment protocols Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-10-30 Thomas M. D'Hooghe
Abstract not available
-
Preface: Emerging importance of real world evidence in reproductive medicine Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-10-29 Thomas D'Hooghe
Abstract not available
-
Preface Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-10-18 Basky Thilaganathan
Abstract not available
-
Corrigendum to “Robotic surgery in ovarian cancer” [Best Pract Res Clin Obst Gynaecol Volume 90 (August 2023) 102391] Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-09-14 Valerio Gallotta, Camilla Certelli, Riccardo Oliva, Andrea Rosati, Alex Federico, Matteo Loverro, Claudio Lodoli, Nazario Foschi, Konstantinos Lathouras, Anna Fagotti, Giovanni Scambia
Abstract not available
-
Robot-assisted laparoscopic pelvic floor surgery: Review Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-09-14 Yair Daykan, Reut Rotem, Barry A. O'Reilly
Minimally invasive surgical techniques have become more common in pelvic floor reconstructive urogynaecological surgery, specifically, robotic-assisted pelvic floor surgery. Female pelvic floor anatomy is complex, and some repairs require highly experienced surgical skills that can be gained more easily using robotic-assisted surgery. A common application of the robotic platform in urogynaecological
-
Intrapartum care and management of complications in women with obesity Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-09-05 Namiko Aleker, Boon H. Lim
Pregnant women with obesity are at considerable risk during their labor and delivery. The aim of obstetric care is the safe delivery of the baby and the maintenance of good health of the mother while providing an ongoing support for the family unit. The awareness and mitigation of risks associated with caring for women who are obese is vital in ensuring continued good outcomes. Transfer of women for
-
The use of pressure balloons in the treatment of first trimester cesarean scar pregnancy Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-29 Ilan E. Timor-Tritsch, Andrea Kaelin Agten, Ana Monteagudo, Giuseppe Calỉ, Francesco D'Antonio
Cesarean scar pregnancy (CSP) is among the most severe complications of cesarean delivery. CSP refers to the abnormal implantation of the gestational sac in the area of the prior cesarean delivery (CD), potentially leading to severe hemorrhage, uterine rupture, or development of placenta accreta spectrum disorders (PAS). The management of women with CSP has not been standardized yet. In women who opted
-
Placental dysfunction in obese women and antenatal surveillance Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-23 Anjum Doshani, Justin C. Konje
Obesity is a significant health concern worldwide and is associated with numerous health complications, including placental dysfunction during pregnancy. Placental dysfunction can lead to adverse outcomes for both the mother and the foetus, such as preeclampsia, gestational diabetes, preterm birth, and foetal growth restriction. Studies have shown that maternal obesity can lead to placental dysfunction
-
Assisted vaginal delivery in the obese patient Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-22 Aoife M. McTiernan, Chetan K. Ruprai, Stephen W. Lindow
Appropriate use of ventouse or obstetric forceps as options in the management of the second-stage of labor is good medical practice. The instruments are not inherently dangerous, however, the manner in which they are used may be. In addition to a working knowledge of the instruments, the operator must have the willingness to abandon an unsuccessful procedure. Awareness that failure of assisted vaginal
-
Robotic-assisted para-aortic lymphadenectomy: Technique and indications in gynecological oncology Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-21 Jordi Ponce, Sergi Fernández, Marc Barahona, José Manuel Martínez, Carlos Ortega, Lola Martí
The benefits of minimally-invasive surgeries have been documented, and they have been established as the preferred approach for gynecological surgeries. With the development of robotic surgery, many highly complex surgeries can benefit from these advantages. Due to the complexity of aortocaval lymphadenectomy, surgical technique protocols have been described to reduce risks by maximizing benefits.
-
An overview of contraception in women with obesity Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-19 Wafaa Ali Belail Hammad, Neerja Gupta, Justin C. Konje
The use of safe and effective contraception is essential for preventing unplanned pregnancy in women of all body sizes. When counseling women with obesity about contraception, it is important to consider the pharmacokinetic alterations of obesity on various modern contraceptive methods. However, evidence is reassuring that most contraceptive methods are safe and effective in women with obesity. Individual
-
Prevention of surgical site infection and sepsis in pregnant obese women Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-19 Emmanuel Ekanem, Nnabuike Chibuoke Ngene, Jagidesa Moodley, Justin Konje
Obesity is a major determinant of health outcomes and is on the increase in women worldwide. It predisposes to surgical site infection (SSI). Risk factors for the SSI include extremes of age, smoking, comorbidities such as hypertension and diabetes, inappropriate vertical abdominal and or uterine wall incisions, increased operating time, subcutaneous layer of 3 cm or more, and unnecessary use of subcutaneous
-
Anesthetic challenges of pregnant obesity women Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-11 Georgia Knight, Mary Mushambi
Obesity causes significant morbidity and increases the mortality risk for both mother and fetus. With an increasing projected prevalence, it is vital that the obstetric anesthetist is equipped with the knowledge and tools to manage these women. A multi-disciplinary team approach and early planning is required. Neuraxial analgesia for labor helps to negate the need for general anesthesia, which is associated
-
Impact of obesity on female puberty and pubertal disorders Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-10 Dvora Bauman
The worldwide epidemic of obesity appears to be one of the crucial health problems. One-third of children and adolescents in the United States are classified as either overweight or obese and 6% of adolescents are severely obese. With the development of high technology, children, and adolescents, spend more time in sedentary life. Together with the availability of consuming fast caloric food, it is
-
Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-10 Philippe Van Trappen
The concept of pelvic sentinel lymph node mapping has been well-investigated in endometrial and cervical cancer. A variety of tracers have been used including blue dye, technetium-99-m (Tc-99 m), and fluorescent tracer indocyanine green. Pelvic sentinel lymph node mapping has shown its safety, efficacy, and diagnostic accuracy, with high sensitivity and negative predictive value of more than 90%, in
-
Providing a standardised educational programme in robot-assisted gynaecological surgery Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-04 Thomas Ind
Standardisation of an educational programme in robotic gynaecological surgery requires careful reflection to ensure that the correct surgeons are selected, that they are trained to the best of their ability, and that they have continued education into their careers. The generally agreed pathways included a proficiency-based progression model for procedures with validated assessment tools used for both
-
Cesarean scar disorder: Management and repair Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-04 Olivier Donnez
Cesarean scar disorder (CSD) is an entity recently defined as uterine niche with at least one primary or 2 secondary symptoms. CSDs can be visualized by hysterosalpingography, transvaginal sonography, saline infusion sonohysterography, hysteroscopy, and magnetic resonance imaging, but diagnosis should be performed by exams able to measure the residual myometrial thickness (RMT). Although there is a
-
Obesity and male infertility Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-08-04 Devini Ameratunga, Alpha Gebeh, Akwasi Amoako
The worldwide prevalence of obesity is increasing among both sexes, with associated impacts on chronic health and medical comorbidities. Similarly, the effects of obesity on reproductive health are increasingly being recognized. Adiposity is associated with reduced fertility in men, with a complex and multifactorial etiology. The reported effects of obesity on semen parameters and impaired fertility
-
Preface Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-07-29 Swati Jha
Abstract not available
-
Routine screening for placenta accreta spectrum Best Pract. Res. Clin. Obstet. Gynaecol. (IF 5.5) Pub Date : 2023-07-22 Amarnath Bhide
Screening for clinically significant placenta accreta spectrum (PAS) is possible with a high degree of accuracy (both sensitivity and specificity >90–95%). The group of women to focus on are those with placenta previa and one or more prior Cesarean deliveries. Screening for PAS not associated with placenta previa is not as productive, and several false negatives have been described. The results of